Cargando…
Cost effectiveness of Iran national plasma contract fractionation program
Plasma derived medicines (PDM) including immunoglobulins, clotting factors and albumin are life saving medicines which due to their high costs are inaccessible for many patients living in developing countries. By contrary substantial volume of plasma as raw materials for production of these medicine...
Autor principal: | Cheraghali, Abdol Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556006/ https://www.ncbi.nlm.nih.gov/pubmed/23351278 http://dx.doi.org/10.1186/2008-2231-20-63 |
Ejemplares similares
-
Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry
por: Cheraghali, Abdol Majid
Publicado: (2012) -
Trends in Iran Pharmaceutical Market
por: Cheraghali, Abdol Majid
Publicado: (2017) -
Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector
por: Emami, Farideh, et al.
Publicado: (2022) -
Implications of Confidential Unit Exclusion in Providing Sufficient Safe Blood for the National Health System
por: Cheraghali, Abdol Majid
Publicado: (2011) -
Heavy Metals Contamination of Table Salt Consumed in Iran
por: Cheraghali, Abdol Majid, et al.
Publicado: (2010)